Welcome to the Hologic Investor Relations page

 

Hologic, Inc. is a leading developer, manufacturer and supplier of premium diagnostic products, medical imaging systems and surgical products. The Company’s core business units focus on diagnostics, breast health, GYN surgical, and skeletal health. With a unified suite of technologies and a robust research and development program, Hologic is dedicated to The Science of Sure.

The Company's Common Stock is listed on the Nasdaq Global Select Market under the trading symbol "HOLX".
 

Announcements

Wednesday, February 4, 2015
Hologic to Present at Three Upcoming Investor Conferences
Read Release
 

Wednesday, January 28, 2015
Hologic Announces Financial Results for First Quarter Fiscal 2015
Read Release
Listen to Webcast
View Presentation
Prepared Remarks

 

Tuesday, January 20, 2015
Hologic Announces Additions to Executive Leadership Team
Read Release
 

Tuesday, January 13, 2015
CEO Stephen MacMillan on Fox Business News
Watch Video

 

Monday, January 12, 2015
Hologic Preliminary Revenues Increased 7% to $653 Million in the First Quarter of Fiscal 2015
Read Release
View Presentation
 

Tuesday, January 6, 2015
Hologic to Present at the 33rd Annual J.P. Morgan Healthcare Conference
Read Release
View Presentation

 

Monday, January 5, 2015
Hologic to Announce Financial Results for the First Quarter of Fiscal 2015 on Wednesday, January 28, 2015
Read Release

 

Monday, December 1, 2014
Hologic Enters the Viral Load Market with CE Mark Certification for the Aptima HIV-1 Viral Load Test
Read Release

 

Thursday, November 6, 2014
President and CEO Steve MacMillan on CNBC Squawk Box
Watch Video

 

Wednesday, November 5, 2014
Hologic Announces Fourth Quarter Fiscal 2014 Operating Results
Read Release
View Presentation

 

Comments? Please fill out our Feedback Form and let us know how you like our Investor website.